Literature DB >> 6127902

Basic pharmacological properties of prenalterol.

H Mattsson, A Hedberg, E Carlsson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6127902     DOI: 10.1111/j.0954-6820.1982.tb00833.x

Source DB:  PubMed          Journal:  Acta Med Scand Suppl        ISSN: 0365-463X


× No keyword cloud information.
  8 in total

1.  Influence of long-term beta receptor stimulation with prenalterol on intrinsic heart rate in rats.

Authors:  E Nylander; U Dahlström
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1984

2.  Effect of prenalterol in asthmatic patients.

Authors:  C G Löfdahl; N Svedmyr
Journal:  Eur J Clin Pharmacol       Date:  1982-10       Impact factor: 2.953

3.  Effect of norepinephrine, prenalterol and metoprolol on the histochemical localization of adenylate cyclase activity in the brown adipose tissue of newborn rat.

Authors:  L Rechardt; H Hervonen
Journal:  Histochemistry       Date:  1982

4.  Acute haemodynamic effects of oral prenalterol in severe heart failure.

Authors:  M C Petch; C Wisbey; O Ormerod; C Scott; R M Goodfellow
Journal:  Br Heart J       Date:  1984-07

5.  Studies of the agonist and antagonist activity of cicloprolol in man.

Authors:  P M McCaffrey; M Burke; J G Riddell; R G Shanks
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

6.  Arrhythmogenic dose of acetylstrophanthidin unchanged by beta-sympathomimetics in conscious dogs.

Authors:  M Haass; G Sponer; U Abshagen
Journal:  Basic Res Cardiol       Date:  1984 Nov-Dec       Impact factor: 17.165

7.  Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade? A six month randomised double blind comparison with placebo.

Authors:  D R Glover; C G Wathen; R G Murray; M C Petch; A L Muir; W A Littler
Journal:  Br Heart J       Date:  1985-02

8.  An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.

Authors:  P M McCaffrey; J G Riddell; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1987-11       Impact factor: 4.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.